A Phase I Pharmacokinetic and Pharmacodynamic Study of PX-12, a Novel Inhibitor of Thioredoxin-1, in Patients With Advanced Solid Tumors
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2250
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2007
Authors
Publisher
American Association for Cancer Research (AACR)